Kathleen Borthwick

Kathleen Borthwick is a declared insider of Passage BIO, Inc., with filings sourced from SEC (Form 4). We count 8 filings; the first trade dates from 31 December 2023 and the latest from 8 January 2026.

Sales make up the whole of the open-market record (4 sales, €44k). Besides market trades, the filings include 4 option exercises. 2026 to date brings no purchases and 1 sale.

The newest entry dates from 12 January 2026: an open-market sale of €33k, in Passage BIO, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.